Ca2+-dependent activator proteins of secretion promote vesicular monoamine uptake.

J Biol Chem

AG Functional Cell Biology, Institute for Integrative Neuroanatomy, Charité Center 2 for Basic Medicine, Philippstr. 12, D-10115 Berlin, Germany.

Published: January 2009

Ca(2+)-dependent activator proteins of secretion (CAPS) 1 and 2 are essential regulators of synaptic vesicle and large dense core vesicle priming in mammalian neurons and neuroendocrine cells. CAPS1 appears to have an additional and as yet unexplained function in vesicular catecholamine uptake or storage as CAPS1-deficient chromaffin cells exhibit strongly reduced vesicular catecholamine levels. Here we describe a role of CAPS proteins in vesicular monoamine uptake. Both CAPS1 and CAPS2 promote monoamine uptake and storage mediated by the vesicular monoamine transporters VMAT1 and VMAT2. Monoamine uptake of vesicular preparations from embryonic brains of CAPS1 deletion mutants is decreased as compared with corresponding preparations from wild type littermates, and anti-CAPS1 or anti-CAPS2 antibodies inhibit monoamine sequestration by synaptic vesicles from adult mouse brain. In addition, overexpression of CAPS1 or CAPS2 enhances vesicular monoamine uptake in Chinese hamster ovary cells that stably express VMAT1 or VMAT2. CAPS function has been linked to the heterotrimeric GTPase G(o), which modulates vesicular monoamine uptake. We found that the expression of CAPS1 is decreased in brain membrane preparations from mice lacking G(o2)alpha, which may explain the reduced monoamine uptake by G(o2)alpha-deficient synaptic vesicles. Accordingly, anti-CAPS1 antibodies do not further reduce monoamine uptake by G(o2)alpha-deficient synaptic vesicles, whereas antibodies directed against CAPS2, whose expression is not altered in G(o2)alpha-deficient brain, still reduce monoamine uptake into G(o2)alpha-deficient vesicles. We conclude that CAPS proteins are involved in optimizing vesicular monoamine uptake and storage mediated by VMAT1 and VMAT2.

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M805328200DOI Listing

Publication Analysis

Top Keywords

monoamine uptake
40
vesicular monoamine
24
monoamine
12
uptake storage
12
vmat1 vmat2
12
synaptic vesicles
12
uptake go2alpha-deficient
12
uptake
11
vesicular
9
ca2+-dependent activator
8

Similar Publications

Advances in Alzheimer's disease control approaches via carbon nanotubes.

Nanomedicine (Lond)

January 2025

Academy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin, China.

Article Synopsis
  • Growing global concern about Alzheimer's disease (AD) stems from its earlier onset and economic impact, leading to neurodegeneration and loss of autonomy.
  • Carbon-based nanomaterials, particularly carbon nanotubes (CNTs), are gaining attention in AD research for their high biocompatibility and potential applications in drug delivery, biosensing, and molecular imaging.
  • CNTs can enhance AD treatment strategies by safely delivering drugs to the brain, detecting neurotransmitter levels, inhibiting harmful protein formation, and promoting regeneration in the central nervous system.
View Article and Find Full Text PDF

Dopamine stimulates CDP-diacylglycerol biosynthesis through D-like receptors, particularly the D subtype most of which is intracellularly localized. CDP-diacylglycerol regulates phosphatidylinositol-4,5-bisphosphate-dependent signaling cascades by serving as obligatory substrate for phosphatidylinositol biosynthesis. Here, we used acute and organotypic brain tissues and cultured cells to explore the mechanism by which extracellular dopamine acts to modulate intracellular CDP-diacylglycerol.

View Article and Find Full Text PDF

A teenager who suffered from left hemiparesis after traumatic brain injury underwent 18F-THK5351 PET 48, 286, and 810 days after the injury. The first scan showed slight uptake in the right corticospinal tract (CST), and the second scan showed intense uptake along the CST, which was significantly reduced in the third scan. The hemiparesis has improved between the first and second scans.

View Article and Find Full Text PDF

Mesoridazine and metoclopramide are cationic drugs that are distributed in the human brain despite being substrates of multidrug resistance protein 1 (MDR1), an efflux transporter expressed at the blood-brain barrier (BBB). We investigated their transport mechanisms at the BBB using hCMEC/D3, a human cerebral microvascular endothelial cell line often used as an in vitro BBB model. The cells exhibited time- and concentration-dependent uptake of mesoridazine and metoclopramide, with K values of 34 and 277 µM, respectively.

View Article and Find Full Text PDF
Article Synopsis
  • D6-[F]FP-(+)-DTBZ is a new imaging agent designed for PET scans that helps diagnose Parkinson's disease (PD) by tracking VMAT2 transporters in the brain.
  • In a study, this radioligand demonstrated efficient production, high purity, and distinct uptake in brain regions associated with PD, showing a greater effectiveness compared to its non-deuterated counterpart.
  • The findings suggest that D6-[F]FP-(+)-DTBZ could serve as a safer, more effective tool for monitoring VMAT2 levels in monoamine neurons, potentially improving PD diagnosis.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!